Glaukos

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. 

CEO
Thomas William Burns
CEOThomas William Burns
Employees
727
Employees727
Headquarters
San Clemente, California
HeadquartersSan Clemente, California
Founded
1998
Founded1998
Employees
727
Employees727

GKOS Key Statistics

Market cap
2.16B
Market cap2.16B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
385.29K
Average volume385.29K
High today
$45.32
High today$45.32
Low today
$43.55
Low today$43.55
Open price
$44.38
Open price$44.38
Volume
404.58K
Volume404.58K
52 Week high
$64.49
52 Week high$64.49
52 Week low
$33.33
52 Week low$33.33

Analyst ratings

45%

of 11 ratings
Buy
45.5%
Hold
45.5%
Sell
9.1%

GKOS Earnings

-$0.83
-$0.55
-$0.28
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 21, After Hours
ActualExpected Feb 21, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.